Survival rates for multiple myeloma vary by the stage at which it’s diagnosed. Overall, the five-year survival rate is 58% according to the American Society of Clinical Oncology.

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, ...

Investigators say they have created a set of models that can use common electronic health record (EHR) data to predict a ...

International Myeloma Foundation Chief Medical Office Joseph Mikhael, MD, shares how the M-Power initiative is addressing ...

The method assesses growth rates of the tumour and detects gene patterns that can forecast outcomes of the patient.

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges ...

Data suggest that “venetoclax usage should be avoided in the general relapsed or refractory multiple myeloma population,” the researchers wrote.

Diagnosing multiple myeloma, also referred to as myeloma, is often a complex process. While this rare blood cancer can cause many complications, it can't be confirmed with a single lab test. Jump ...

The International Myeloma Working Group (IMWG) first established formal diagnostic criteria for multiple myeloma (MM) and its precursor condition in 2003, 17 with an update in 2014 that introduced ...

Multiple myeloma has an incidence of approximately 4-5 new cases per 100,000 inhabitants per year. This means that around 3000 new cases are diagnosed each year in Spain.